Cargando…
Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression
Ketamine and lithium both inhibit glycogen synthase kinase 3. In addition, lithium and ketamine have synergistic antidepressant-like effects at individually subeffective doses in rodents. We hypothesized that ketamine's antidepressant effects would be improved by therapeutic doses of lithium ve...
Autores principales: | Xu, Annie J., Niciu, Mark J., Lundin, Nancy B., Luckenbaugh, David A., Ionescu, Dawn F., Richards, Erica M., Vande Voort, Jennifer L., Ballard, Elizabeth D., Brutsche, Nancy E., Machado-Vieira, Rodrigo, Zarate, Carlos A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475570/ https://www.ncbi.nlm.nih.gov/pubmed/26137324 http://dx.doi.org/10.1155/2015/858251 |
Ejemplares similares
-
Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder
por: Niciu, Mark J., et al.
Publicado: (2014) -
The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020) -
Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depressive Disorder
por: Kadriu, Bashkim, et al.
Publicado: (2017) -
Biomarkers of ketamine’s antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology
por: Alario, Alexandra A., et al.
Publicado: (2021) -
Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
por: Lally, N, et al.
Publicado: (2014)